Emerging studies suggest Retatrutide , a dual stimulator targeting both incretin and another hormone, could offer a promising advancement for weight treatment. Initial patient tests have indicated impressive losses in body tissue, possibly surpassing current weight-loss treatments. Nevertheless ,